Advanced search
Publication Cover
Journal of Asthma and Allergy Volume 7, 2014 - Issue
Submit an article Journal homepage
650
Views
87
CrossRef citations to date
0
Altmetric
Review

Dupilumab: a novel treatment for asthma

Alessandro Vatrella1 Department of Medicine and Surgery, University of Salerno, Salerno, ItalyCorrespondence[email protected]
,
Immacolata Fabozzi1 Department of Medicine and Surgery, University of Salerno, Salerno, Italy
,
Cecilia Calabrese2 Department of Cardiothoracic and Respiratory Sciences, Second University of Naples, Naples, Italy
,
Rosario Maselli3 Department of Medical and Surgical Sciences, University Magna Græcia, Catanzaro, Italy
&
Girolamo Pelaia3 Department of Medical and Surgical Sciences, University Magna Græcia, Catanzaro, Italy
Pages 123-130 | Published online: 04 Sep 2014

Citations (87)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (15)

Yuji Tohda,Hisako Matsumoto,Masanori Miyata,Yurie Taguchi,Maki Ueyama,Florence Joulain,Ichiro Arakawa,. (2022) Cost-effectiveness analysis of dupilumab among patients with oral corticosteroid-dependent uncontrolled severe asthma in Japan. Journal of Asthma 59:11, pages 2162-2173.
Read now
Alfredo J Lucendo. (2022) Drug treatment strategies for eosinophilic esophagitis in adults. Expert Opinion on Pharmacotherapy 23:7, pages 827-840.
Read now
Sonsoles Tamarit-Sebastian, Francisco Miguel Ferrer-Soler & Alfredo J Lucendo. (2022) Current options and investigational drugs for the treatment of eosinophilic esophagitis. Expert Opinion on Investigational Drugs 31:2, pages 193-210.
Read now
Alessandro Vatrella, Angelantonio Maglio, Simona Pellegrino, Corrado Pelaia, Cristiana Stellato, Girolamo Pelaia & Carolina Vitale. (2020) Phenotyping severe asthma: a rationale for biologic therapy. Expert Review of Precision Medicine and Drug Development 5:4, pages 265-274.
Read now
Angela Moran & Ian D Pavord. (2020) Anti-IL-4/IL-13 for the treatment of asthma: the story so far. Expert Opinion on Biological Therapy 20:3, pages 283-294.
Read now
Alfredo J Lucendo. (2020) Pharmacological treatments for eosinophilic esophagitis: current options and emerging therapies. Expert Review of Clinical Immunology 16:1, pages 63-77.
Read now
Neil S. Skolnik & Sean P. Carnahan. (2019) Primary care of asthma: new options for severe eosinophilic asthma. Current Medical Research and Opinion 35:7, pages 1309-1318.
Read now
Olabola Awosika, Lori Kim, Momina Mazhar, Monica Rengifo-Pardo & Alison Ehrlich. (2018) Profile of dupilumab and its potential in the treatment of inadequately controlled moderate-to-severe atopic dermatitis. Clinical, Cosmetic and Investigational Dermatology 11, pages 41-49.
Read now
Pilar Barranco, Elsa Phillips-Angles, Javier Dominguez-Ortega & Santiago Quirce. (2017) Dupilumab in the management of moderate-to-severe asthma: the data so far. Therapeutics and Clinical Risk Management 13, pages 1139-1149.
Read now
Francesco Menzella, Carla Galeone, Francesca Bertolini, Claudia Castagnetti & Nicola Facciolongo. (2017) Innovative treatments for severe refractory asthma: how to choose the right option for the right patient?. Journal of Asthma and Allergy 10, pages 237-247.
Read now
Corrado Pelaia, Alessandro Vatrella, Luca Gallelli, Rosa Terracciano, Paolo Navalesi, Rosario Maselli & Girolamo Pelaia. (2017) Dupilumab for the treatment of asthma. Expert Opinion on Biological Therapy 17:12, pages 1565-1572.
Read now
Carolina Vitale, Angelantonio Maglio, Corrado Pelaia & Alessandro Vatrella. (2017) Long-term treatment in pediatric asthma: an update on chemical pharmacotherapy. Expert Opinion on Pharmacotherapy 18:7, pages 667-676.
Read now
Giuseppe Santini, Nadia Mores, Mario Malerba, Chiara Mondino, Roberta Anzivino, Giuseppe Macis & Paolo Montuschi. (2017) Dupilumab for the treatment of asthma. Expert Opinion on Investigational Drugs 26:3, pages 357-366.
Read now
Richard Russell & Christopher Brightling. (2016) Mepolizumab for the reduction of exacerbations in severe eosinophilic asthma. Expert Review of Respiratory Medicine 10:6, pages 607-617.
Read now
Laura De Ferrari, Alessandra Chiappori, Diego Bagnasco, Anna Maria Riccio, Giovanni Passalacqua & Giorgio Walter Canonica. (2016) Molecular phenotyping and biomarker development: are we on our way towards targeted therapy for severe asthma?. Expert Review of Respiratory Medicine 10:1, pages 29-38.
Read now

Articles from other publishers (72)

P. Lemal, K. May, S. König, M. Schroyen & N. Gengler. (2023) Invited review: From heat stress to disease—Immune response and candidate genes involved in cattle thermotolerance. Journal of Dairy Science 106:7, pages 4471-4488.
Crossref
José Palacios-García, Cristina Porras-González, Ramón Moreno-Luna, Juan Maza-Solano, Juan Polo-Padillo, José Luis Muñoz-Bravo & Serafín Sánchez-Gómez. (2023) Role of Fibroblasts in Chronic Inflammatory Signalling in Chronic Rhinosinusitis with Nasal Polyps—A Systematic Review. Journal of Clinical Medicine 12:9, pages 3280.
Crossref
Yujin Jin, Warisraporn Tangchang, Oh. Seong Kwon, Ji-Yun Lee, Kyung-Sun Heo & Hwa-Young Son. (2023) Ginsenoside Rh1 ameliorates the asthma and allergic inflammation via inhibiting Akt, MAPK, and NF-κB signaling pathways in vitro and in vivo. Life Sciences 321, pages 121607.
Crossref
Zaid W. El‐Husseini, Judith M. Vonk, Maarten van den Berge, Reinoud Gosens & Gerard H. Koppelman. (2023) Association of asthma genetic variants with asthma‐associated traits reveals molecular pathways of eosinophilic asthma. Clinical and Translational Allergy 13:4.
Crossref
Felisbela Gomes & Shih-Lung Cheng. (2023) Pathophysiology, Therapeutic Targets, and Future Therapeutic Alternatives in COPD: Focus on the Importance of the Cholinergic System. Biomolecules 13:3, pages 476.
Crossref
Ilka Jorde, Jens Schreiber & Sabine Stegemann-Koniszewski. (2022) The Role of Staphylococcus aureus and Its Toxins in the Pathogenesis of Allergic Asthma. International Journal of Molecular Sciences 24:1, pages 654.
Crossref
Matthew T. Shephard, Marwan M. Merkhan & Nicholas R. Forsyth. (2022) Human Mesenchymal Stem Cell Secretome Driven T Cell Immunomodulation Is IL-10 Dependent. International Journal of Molecular Sciences 23:21, pages 13596.
Crossref
Lola Loewenthal & Andrew Menzies-Gow. (2022) FeNO in Asthma. Seminars in Respiratory and Critical Care Medicine 43:05, pages 635-645.
Crossref
M. Tabardel, E. Clark, P. Demoly & D. Caimmi. (2022) Les anticorps monoclonaux à disposition des allergologues pour traiter l’asthme sévère. Revue Française d'Allergologie 62:6, pages 572-577.
Crossref
Luigino Calzetta, Marina Aiello, Annalisa Frizzelli, Elena Pistocchini, Beatrice Ludovica Ritondo, Paola Rogliani & Alfredo Chetta. (2022) Investigational Treatments in Phase I and II Clinical Trials: A Systematic Review in Asthma. Biomedicines 10:9, pages 2330.
Crossref
Henrik Hedegaard Pliess Larsen, Ida Vittrup, Iben Frier Ruge, Jesper Elberling, Lone Skov, Kristina Ibler, Gregor Borut Ernst Jemec, Charlotte Gotthard Mørtz, Rasmus Overgaard Bach, Carsten Bindslev-Jensen, Maiken Glud Dalager, Tove Agner, Mette Deleuran, Christian Vestergaard & Jacob Pontoppidan Thyssen. (2022) Severe and ChRonic Atopic dermatitis Treatment CoHort (SCRATCH): A Danish Real-world Evidence Atopic Dermatitis Treatment Registry. Acta Dermato-Venereologica 102, pages adv00760.
Crossref
Corrado Pelaia, Giulia Pelaia, Claudia Crimi, Angelantonio Maglio, Giuseppe Armentaro, Cecilia Calabrese, Angela Sciacqua, Luca Gallelli & Alessandro Vatrella. (2022) Biological Therapy of Severe Asthma with Dupilumab, a Dual Receptor Antagonist of Interleukins 4 and 13. Vaccines 10:6, pages 974.
Crossref
V. V. Salmin, A. V. Morgun, R. Ya. Olovyannikova, V. A. Kutyakov, E. V. Lychkovskaya, E. B. Brusina & A. B. Salmina. (2022) Atmospheric Reactive Oxygen Species and Some Aspects of the Antiviral Protection at the Respiratory Epithelium. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry 16:2, pages 79-90.
Crossref
Aaliya L. Ali, Namrata P. Nailwal & Gaurav M. Doshi. (2022) Emerging Role of Interleukins for the Assessment and Treatment of Liver Diseases. Endocrine, Metabolic & Immune Disorders - Drug Targets 22:4, pages 371-382.
Crossref
Corrado Pelaia, Enrico Heffler, Claudia Crimi, Angelantonio Maglio, Alessandro Vatrella, Girolamo Pelaia & Giorgio Walter Canonica. (2022) Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets. Frontiers in Pharmacology 13.
Crossref
Matteo GHISA, Giorgio LASERRA, Daria MANIERO, Elisa MARABOTTO, Brigida BARBERIO, Filippo PELIZZARO, Ilenia BARBUSCIO, Fabiana ZINGONE, Vincenzo SAVARINO & Edoardo SAVARINO. (2022) Eosinophilic esophagitis: from pathophysiology to management. Minerva Gastroenterology 68:1.
Crossref
Florent Carsuzaa, Émilie Béquignon, Xavier Dufour, Guillaume de Bonnecaze, Jean-Claude Lecron & Laure Favot. (2021) Cytokine Signature and Involvement in Chronic Rhinosinusitis with Nasal Polyps. International Journal of Molecular Sciences 23:1, pages 417.
Crossref
Yuko Abe, Yasuhiko Suga, Kiyoharu Fukushima, Hayase Ohata, Takayuki Niitsu, Hiroshi Nabeshima, Yasuharu Nagahama, Hiroshi Kida & Atsushi Kumanogoh. (2021) Advances and Challenges of Antibody Therapeutics for Severe Bronchial Asthma. International Journal of Molecular Sciences 23:1, pages 83.
Crossref
Jenny Huang & Milind Pansare. (2021) New Treatments for Asthma. Immunology and Allergy Clinics of North America 41:4, pages 555-569.
Crossref
O. M. Kurbacheva3, M. E. Dyneva & N. I. Ilina. (2021) Dupilumab: basic aspects and applications to T2-mediated diseases. Meditsinskiy sovet = Medical Council:16, pages 186-196.
Crossref
V.V. Salmin, A.V. Morgun, R.Ya. Olovyannikova, V.A. Kutyakov, E.V. Lychkovskaya, E.B. Brusina & A.B. Salmina. (2021) Atmospheric reactive oxygen species and some aspects of the antiviral protection of the respiratory epithelium. Biomeditsinskaya Khimiya 67:5, pages 383-393.
Crossref
William W. Busse, Monica Kraft, Klaus F. Rabe, Yamo Deniz, Paul J. Rowe, Marcella Ruddy & Mario Castro. (2021) Understanding the key issues in the treatment of uncontrolled persistent asthma with type 2 inflammation. European Respiratory Journal 58:2, pages 2003393.
Crossref
Christopher Conlon, Lauren Pupa, Edward M. Reece, Carrie K. Chu, Jessie Z. Yu, Joshua Vorstenbosch & Sebastian Winocour. (2021) When Benign Becomes Cancer: Malignant Degeneration of Chronic Inflammation. Seminars in Plastic Surgery 35:03, pages 159-163.
Crossref
Megan M. Cleary, Narendra Bharathy, Jinu Abraham, Jin-Ah Kim, Erin R. Rudzinski, Joel E. Michalek & Charles Keller. (2021) Interleukin-4 Receptor Inhibition Targeting Metastasis Independent of Macrophages. Molecular Cancer Therapeutics 20:5, pages 906-914.
Crossref
Miramgul E. Dyneva, Gulyumkhan E. Aminova, Oksana Kurbacheva & Natalya I. Il'ina. (2021) Dupilumab: new opportunities for the treatment of asthma and chronic rhinosinusitis with nasal polyps. Russian Journal of Allergy 18:1, pages 18-31.
Crossref
Li-Yen Lee, Geena Suet Yin Hew, Meenu Mehta, Shakti D. Shukla, Saurabh Satija, Navneet Khurana, Krishnan Anand, Harish Dureja, Sachin Kumar Singh, Vijay Mishra, Pankaj Kumar Singh, Monica Gulati, Parteek Prasher, Alaa A.A. Aljabali, Murtaza M. Tambuwala, Lakshmi Thangavelu, Jithendra Panneerselvam, Gaurav Gupta, Flavia C. Zacconi, Madhur Shastri, Niraj Kumar Jha, Dikaia Xenaki, Ronan MacLoughlin, Brian G. Oliver, Dinesh Kumar Chellappan & Kamal Dua. (2021) Targeting eosinophils in respiratory diseases: Biological axis, emerging therapeutics and treatment modalities. Life Sciences 267, pages 118973.
Crossref
Luigino Calzetta, Maria Gabriella Matera, Angelo Coppola & Paola Rogliani. (2021) Prospects for severe asthma treatment. Current Opinion in Pharmacology 56, pages 52-60.
Crossref
Joytri Dutta, Sabita Singh, Archita Ray & Ulaganathan Mabalirajan. 2021. Targeting Cellular Signalling Pathways in Lung Diseases. Targeting Cellular Signalling Pathways in Lung Diseases 97 125 .
Sheikh Rayees & Inshah DinSheikh Rayees & Inshah Din. 2021. Asthma: Pathophysiology, Herbal and Modern Therapeutic Interventions. Asthma: Pathophysiology, Herbal and Modern Therapeutic Interventions 27 32 .
Claas-Tido Peck, Sarah Strauß, Gregory L. Stahl, Peter-Maria Vogt & Marc N. Busche. (2020) Mannose-binding lectin (MBL) and the lectin complement pathway play a role in cutaneous ischemia and reperfusion injury. Innovative Surgical Sciences 5:1-2, pages 43-51.
Crossref
Rita Kachru, Kellie Lim & Lorraine Anderson. (2020) The Role of Biologics and Precision-Based Medicine in Treating Atopic Diseases in Children. Current Treatment Options in Allergy 7:3, pages 312-325.
Crossref
Alfredo J. Lucendo & Piedad López-Sánchez. (2020) Targeted Therapies for Eosinophilic Gastrointestinal Disorders. BioDrugs 34:4, pages 477-493.
Crossref
Katherine L. Tison, Meera Patrawala & Michael S. Blaiss. (2020) Monoclonal Antibody Therapy in Childhood Asthma. Current Allergy and Asthma Reports 20:7.
Crossref
Paola Rogliani, Luigino Calzetta, Maria Gabriella Matera, Rossella Laitano, Beatrice Ludovica Ritondo, Nicola A. Hanania & Mario Cazzola. (2019) Severe Asthma and Biological Therapy: When, Which, and for Whom. Pulmonary Therapy 6:1, pages 47-66.
Crossref
Arash R. Safavi & Michael P. Platt. (2020) Biologic Therapeutics and Their Role in Allergic Disease of the Unified Airway. Current Otorhinolaryngology Reports 8:2, pages 185-190.
Crossref
Kazuto Matsunaga, Norito Katoh, Shigeharu Fujieda, Kenji Izuhara & Keiji Oishi. (2020) Dupilumab: Basic aspects and applications to allergic diseases. Allergology International 69:2, pages 187-196.
Crossref
Michael C Peters & Sally E Wenzel. (2020) Intersection of biology and therapeutics: type 2 targeted therapeutics for adult asthma. The Lancet 395:10221, pages 371-383.
Crossref
Alvaro  Pedroza Melendez,  José G  Huerta-López & Juana Amanda Pizaña-Montero. (2020) Biomarcadores para el diagnóstico endotípico del asma y su tratamiento. Alergia, Asma e Inmunología Pediátricas 29:3, pages 99-107.
Crossref
Michelle Campion, Leila Smith, Solène Gatault, Charles Métais, Jörg Buddenkotte & Martin Steinhoff. (2019) Interleukin‐4 and interleukin‐13 evoke scratching behaviour in mice. Experimental Dermatology 28:12, pages 1501-1504.
Crossref
Seyyed Shamsadin Athari. (2019) Targeting cell signaling in allergic asthma. Signal Transduction and Targeted Therapy 4:1.
Crossref
Jenny Huang & Milind Pansare. (2019) New Treatments for Asthma. Pediatric Clinics of North America 66:5, pages 925-939.
Crossref
Jéssica Vieira Cerqueira, Cássio Santana Meira, Emanuelle de Souza Santos, Luciana Souza de Aragão França, Juliana Fraga Vasconcelos, Carolina Kymie Vasques Nonaka, Tarcísio Luna de Melo, José Maurício dos Santos Filho, Diogo Rodrigo Magalhães Moreira & Milena Botelho Pereira Soares. (2019) Anti-inflammatory activity of SintMed65, an N-acylhydrazone derivative, in a mouse model of allergic airway inflammation. International Immunopharmacology 75, pages 105735.
Crossref
Li-chun Tian, Qing-qing Zhu, Jun Li, Ai-jie Liu & Guang-rui Huang. (2019) Aerosol Inhalation-mediated Delivery of an Adeno-associated Virus 5-expressed Antagonistic Interleukin-4 Mutant Ameliorates Experimental Murine Asthma. Archives of Medical Research 50:6, pages 384-392.
Crossref
José A. Fernández Robledo, Raghavendra Yadavalli, Bassem Allam, Emmanuelle Pales Espinosa, Marco Gerdol, Samuele Greco, Rebecca J. Stevick, Marta Gómez-Chiarri, Ying Zhang, Cynthia A. Heil, Adrienne N. Tracy, David Bishop-Bailey & Michael J. Metzger. (2019) From the raw bar to the bench: Bivalves as models for human health. Developmental & Comparative Immunology 92, pages 260-282.
Crossref
Kiran Kumar Rathinam, Justin Jacob Abraham & Thangavel Mahalingam Vijayakumar. (2019) Dupilumab in the Treatment of Moderate to Severe Asthma: An Evidence-Based Review. Current Therapeutic Research 91, pages 45-51.
Crossref
Hiroshi Ohnishi & Akihito Yokoyama. 2019. Advances in Asthma. Advances in Asthma 177 189 .
Helen Saul. (2018) Type 2 Inflammation and the Evolving Profile of Uncontrolled Persistent Asthma. European Medical Journal, pages 24-33.
Crossref
Christian Domingo, Oscar Palomares, David A. Sandham, Veit J. Erpenbeck & Pablo Altman. (2018) The prostaglandin D2 receptor 2 pathway in asthma: a key player in airway inflammation. Respiratory Research 19:1.
Crossref
Anmol Pitliya, Sudarshana Datta, Arzu Kalayci, Farima Kahe, Sadaf Sharfaei, Mehrian Jafarizade, Sogand Goudarzi & Gerald Chi. (2018) Eosinophilic inflammation in spontaneous coronary artery dissection: A potential therapeutic target?. Medical Hypotheses 121, pages 91-94.
Crossref
Paul Scutt. (2018) Discovering Asthma Paradigms in an Evolving Landscape: Expert Perspectives. EMJ Respiratory, pages 62-70.
Crossref
Erwin W. Gelfand & Michaela Schedel. (2018) Molecular Endotypes Contribute to the Heterogeneity of Asthma. Immunology and Allergy Clinics of North America 38:4, pages 655-665.
Crossref
Imran H. Iftikhar, Mathew Schimmel, William Bender, Colin Swenson & David Amrol. (2018) Comparative Efficacy of Anti IL-4, IL-5 and IL-13 Drugs for Treatment of Eosinophilic Asthma: A Network Meta-analysis. Lung 196:5, pages 517-530.
Crossref
Sean A. McGhee. (2018) Biologics in pediatric lung disease. Current Opinion in Pediatrics 30:3, pages 366-371.
Crossref
Yue Huo & Hong-Yu Zhang. (2018) Genetic Mechanisms of Asthma and the Implications for Drug Repositioning. Genes 9:5, pages 237.
Crossref
Harold Kim, Anne K. Ellis, David Fischer, Mary Noseworthy, Ron Olivenstein, Kenneth R. Chapman & Jason Lee. (2017) Asthma biomarkers in the age of biologics. Allergy, Asthma & Clinical Immunology 13:1.
Crossref
Michael S. Blaiss, Mario Castro, Bradley E. Chipps, Myron Zitt, Reynold A. PanettieriJr.Jr. & Michael B. Foggs. (2017) Guiding principles for use of newer biologics and bronchial thermoplasty for patients with severe asthma. Annals of Allergy, Asthma & Immunology 119:6, pages 533-540.
Crossref
Daniel M. Beswick, Stacey T. Gray & Timothy L. Smith. (2017) Pharmacological Management of Chronic Rhinosinusitis: Current and Evolving Treatments. Drugs 77:16, pages 1713-1721.
Crossref
K. D. Quinn, M. Schedel, Y. Nkrumah-Elie, A. Joetham, M. Armstrong, C. Cruickshank-Quinn, R. Reisdorph, E. W. Gelfand & N. Reisdorph. (2017) Dysregulation of metabolic pathways in a mouse model of allergic asthma. Allergy 72:9, pages 1327-1337.
Crossref
Alexander C. Barnes, Alexander D. Blandford & Julian D. Perry. (2017) Cicatricial ectropion in a patient treated with dupilumab. American Journal of Ophthalmology Case Reports 7, pages 120-122.
Crossref
N Philips. (2017) Inhibition of Interleukin-4 Signalling in the Treatment of Atopic Dermatitis and Allergic Asthma. Global Journal of Allergy, pages 019-021.
Crossref
Catherine S. Tripp, Carolyn Cuff, Andrew L. Campbell, Barbara A. Hendrickson, Jeff Voss, Terry Melim, Chengbin Wu, Andrew D. Cherniack & Kenneth Kim. (2017) RPC4046, A Novel Anti-interleukin-13 Antibody, Blocks IL-13 Binding to IL-13 α1 and α2 Receptors: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation First-in-Human Study. Advances in Therapy 34:6, pages 1364-1381.
Crossref
Iris M. Otani & Kari C. Nadeau. (2017) Biologic Therapies for Immunoglobulin E–mediated Food Allergy and Eosinophilic Esophagitis. Immunology and Allergy Clinics of North America 37:2, pages 369-396.
Crossref
Li Xiao, Tinghui Li, Mengmeng Ding, Jiezuan Yang, José Rodríguez-Corrales, Stephen M. LaConte, Nicholas Nacey, David B. Weiss, Li Jin, Harry C. Dorn & Xudong Li. (2017) Detecting Chronic Post-Traumatic Osteomyelitis of Mouse Tibia via an IL-13Rα2 Targeted Metallofullerene Magnetic Resonance Imaging Probe. Bioconjugate Chemistry 28:2, pages 649-658.
Crossref
Moritz Berker, Larissa Johanna Frank, Anja Lidwina Geßner, Niklas Grassl, Anne Verena Holtermann, Stefanie Höppner, Christian Kraef, Martin Dominik Leclaire, Pia Maier, David Alexander Christian Messerer, Lino Möhrmann, Jan Philipp Nieke, Diana Schoch, Dominik Soll & Christina Marianne Paulina Woopen. (2017) Allergies – A T cells perspective in the era beyond the TH1/TH2 paradigm. Clinical Immunology 174, pages 73-83.
Crossref
Girolamo Pelaia, Alessandro Vatrella & Rosario MaselliGirolamo Pelaia, Alessandro Vatrella & Rosario Maselli. 2017. Asthma: Targeted Biological Therapies. Asthma: Targeted Biological Therapies 67 81 .
Kara Vale. (2016) Targeting the JAK-STAT pathway in the treatment of ‘Th2-high’ severe asthma. Future Medicinal Chemistry 8:4, pages 405-419.
Crossref
Diego Bagnasco, Matteo Ferrando, Gilda Varricchi, Giovanni Passalacqua & Giorgio Walter Canonica. (2016) A Critical Evaluation of Anti-IL-13 and Anti-IL-4 Strategies in Severe Asthma. International Archives of Allergy and Immunology 170:2, pages 122-131.
Crossref
Karen H. Calhoun. (2015) Asthma treatments: new and emerging therapies. International Forum of Allergy & Rhinology 5:S1, pages S76-S81.
Crossref
Larisa J. GeskinSara Viragova, Donna B. Stolz & Patrizia Fuschiotti. (2015) Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation. Blood 125:18, pages 2798-2805.
Crossref
Andrea Montes-Torres, Mar Llamas-Velasco, Alejandra Pérez-Plaza, Guillermo Solano-López & Javier Sánchez-Pérez. (2015) Biological Treatments in Atopic Dermatitis. Journal of Clinical Medicine 4:4, pages 593-613.
Crossref
Samir Wadhawan, Heiko Runz & Julja Burchard. (2015) The genome as pharmacopeia: Association of genetic dose with phenotypic response. Biochemical Pharmacology 94:4, pages 229-240.
Crossref
Dong-Ho Nahm. (2015) Present and future of allergen immunotherapy for allergic diseases. Journal of the Korean Medical Association 58:5, pages 433.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.